BURN CARE AND WOUND CARE MARKET ANALYSIS

Burn Care and Wound Care Market, by Product Type (Topical Agents {Antibiotics, Antiseptic, Antifungal, and Others {Chlorhexidine, among others}}, Wound Therapy Device {Negative Pressure Therapy Device, Hyperbaric Oxygen Equipment, Pressure Relief Devices, and Others {Electrical Stimulation Devices}}, Surgical Wound Care Products {Sutures, Staplers, and Others {Tissue Adhesives, Sealants and Glues}}, Skin Grafts {Split-thickness Grafts, Full-thickness Grafts, and Composite Grafts}, and Advanced Dressing {Foam Dressing, Collagen Dressing, Hydrogel Dressing, and Others {Hydrocolloid, Alginate, among others}}, and Traditional Burn Care {Medical Tapes, Dressings, and Cleansing Agents}), by Application (Burn Degree {First Degree, Second Degree, Third Degree, and Fourth Degree}, and Wound Type (Surgical Wounds, Ulcers {Pressure Ulcers, Diabetic Foot Ulcers, and Arterial and Venous Ulcers}, Traumatic Wounds, and Others {Microbial Infection, among others})), by End User (Hospitals and Clinics, Burn Care Centers, and Others {Home Care, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Nov 2022
Code : CMI4836
Pages :180
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Increasing research and development activities for introduction of novel burn care and wound care products is expected to drive market growth over the forecast period.

For instance, in February 2021, a new research project led by Lancaster University (UK) was launched to explore the potential of plasma-activated antimicrobial hydrogel therapy (PAHT) for the treatment of diabetic foot ulcer (DFU).

Key players operating in the market are focusing on launching new burn care and wound care products, which is expected to drive growth of the global burn care and wound care market over the forecast period.

For instance, in September 2020, MiMedx Group, Inc., a U.S.-based advanced wound care and therapeutic biologics company, announced the launch of its new advanced wound care product called EpiCord Expandable, a placental tissue allograft for the treatment of diabetic foot ulcers. The new EpiCord Expandable is designed in a way that the allograft covers up to twice the surface area once expanded in order to support the advanced wound care needs of patients suffering from chronic as well as hard-to-heal wounds.